z-logo
open-access-imgOpen Access
Diagnostic Guidelines for Kawasaki Disease
Author(s) -
Dajani As,
Alan L. Bisno,
Kyung J. Chung,
Durack Dt,
Michael A. Gerber,
Kaplan El,
D. Millard,
M. F. Randolph,
Stanford T. Shulman,
Kathryn A. Taubert,
Chatrchai Watanakunakorn
Publication year - 2001
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.103.2.335
Subject(s) - medicine , kawasaki disease , mucocutaneous lymph node syndrome , dermatology , erythema , disease , etiology , heart disease , rash , pediatrics , surgery , artery
Kawasaki disease, or mucocutaneous lymph node syndrome, is a disease of unknown etiology that most frequently (80% of the time) affects infants and children under 5 years of age. Accurate diagnosis and early therapeutic interventions such as aspirin and intravenous g-globulin can decrease the approximately 20% risk of developing coronary artery abnormalities. A specific diagnostic test does not exist. Thus, diagnosis of Kawasaki disease is based on characteristic clinical signs and symptoms, which are classified as principal clinical findings and other clinical and laboratory findings. The male-to-female ratio among patients with Kawasaki disease is 1.5 ;1. Children of nearly all racial backgrounds are affected. Recurrences and cases in siblings are seen only occasionally.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom